[S-15] S-15: Applying TDM to HIV and TB therapy

[S-15-4] Therapeutic drug monitoring of rifampicin & isoniazid and implications of acetylator genotype on plasma levels

Prerna Kulbhushan Chawla¹, Rohan V. Lokhande², Prasad R. Naik³, Alpa J. Dherai⁴, Zarir F. Udwadia⁵, Ashok A. Mahashur⁶, Rajeev Soman⁷, Jignesh Patel⁸, Tester F. Ashavaid⁹ (1.P.D. HINDUJA HOSPITAL & MRC, 2.P.D. Hinduja National Hospital and Medical Research Centre, 3.P.D. Hinduja National Hospital and Medical Research Centre, 4.P.D. Hinduja National Hospital and Medical Research Centre, 5.P.D. Hinduja National Hospital and Medical Research Centre, 6.P.D. Hinduja National Hospital and Medical Research Centre, 7.P.D. Hinduja National Hospital and Medical Research Centre, 8.P.D. Hinduja National Hospital and Medical Research Centre, 9.P.D. Hinduja National Hospital and Medical Research Centre)

キーワード：Rifampicin, Isoniazid, NAT2 acetylator status, Therapeutic Drug Monitoring, India